DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20222294
Published: 2022-08-29

The protein C deficiency and its effects on in-vitro fertilization outcome and recurrent pregnancy loss: a Syrian cohort study

Fadi Khoury, Haya Deeb, Rana Jarouj, Hanna Khoury, Nawras Alhalabi, Marwan Alhalabi

Abstract


Background: Protein C deficiency is a rare disease; it could be primary or secondary. Female patients with protein C deficiency may develop pregnancy-associated thrombosis. The clear association between the protein C deficiency and fertility or in-vitro fertilization (IVF) results has not been known yet. In our study, we aimed to determine the prevalence of protein C deficiency in Syrian infertile women and to assess the impact of protein C deficiency on abortion, recurrent IVF Failure, and IVF results.

Methods: the electronic patients’ results were retrospectively screened. A total of 238 women, who had IVF cycles between January 2012 and December 2017 in a tertiary care hospital, met our including criteria.

Results: the prevalence of protein C deficiency was 13.45%. There was a significant association between the protein C level and recurrent pregnancy loss (RPL). Furthermore, the protein C deficiency has an impact on the IVF results. Additionally, we did not find any association between protein C deficiency and age or number of previous IVF cycles.

Conclusions: the protein C could be the hidden factor that affects IVF results. More research should be done to better understanding the role of protein C in infertility and IVF.


Keywords


Protein C deficiency, IVF, RPL, Infertility, Syria

Full Text:

PDF

References


Gupta A, Patibandla S. Protein C Deficiency. Treasure Island (FL): StatPearls Publishing: StatPearls Publishing. 2021.

Mannucci PM, Franchini M. Classic thrombophilic gene variants. Thrombosis haemostasis. 2015;114:885-9.

Tait RC, Walker ID, Reitsma PH. Prevalence of protein C deficiency in the healthy population. Thrombosis haemostasis 1995;73:87-93.

Alhenc-Gelas M, Gandrille S, Aubry ML, Aiach M. Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein S. Thrombosis haemostasis. 2000;83:86-92.

Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ, Meijer K, Leebeek FW. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ (Clinical research ed). 2017;359:j4452.

Cheng Y, Kawamura K, Deguchi M, Takae S, Mulders SM, Hsueh AJ. Intraovarian thrombin and activated protein C signaling system regulates steroidogenesis during the periovulatory period. Molecular endocrinol. (Baltimore, Md). 2012;26:331-40.

España F, Navarro S, Medina P, Zorio E, Estellés A. The role of protein C inhibitor in human reproduction. Seminars thrombosis hemostasis. 2007;33:41-5.

Elisen MG, van Kooij RJ, Nolte MA. Protein C inhibitor may modulate human sperm-oocyte interactions. Biol Reproduct. 1998;58:670-7.

Brenner B, Shapira A, Bahari C, Haimovich L, Seligsohn U. Hereditary protein C deficiency during pregnancy. Am J Obstetr Gynecol. 1987;157:1160-1.

Younis JS, Ben-Ami M, Izhaki I, Brenner B, Sarig G. Reduced protein C Global assay level in infertile women prior to IVF-ET treatment. J Assisted Reproduct Genetics. 2014;31:101-7.

Miyaji M, Deguchi M, Tanimura K. Clinical factors associated with pregnancy outcome in women with recurrent pregnancy loss. Gynecological Endocrinol. 2019;35:913-8.

Besharat M, Tabandeh A, Keshtkar A, Mobasheri E, Besharat S, Joshaghani H. Evaluation of Some Plasma Coagulation Factors in Women with Spontaneous Miscarriage. Int J Fertil Steril. 2015;9:309-12.

El Masry S, Azzam H, Youssef H, Othman M, Awad M. Reduced Protein C Global Assay Levels in Infertile Women with in vitro Fertilization Failure: A Pilot Study. Acta Haematologica. 2018;139:1-6.

Yu Ng EH, Yeung WS, Yee Lan Lau E, So WW, Ho PC. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Human Reproduct (Oxford, England). 2000;15:250-5.

Blockeel C, Engels S, De Vos M. Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reproduct Biomed Online. 2012;24:272-80.

Albuquerque LE, Tso LO, Saconato H, Albuquerque MC, Macedo CR. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles. Cochrane Database Systematic Rev. 2013;2013:Cd002808.

Ayadurai T, Muniandy S, Omar SZ. Thrombophilia investigation in Malaysian women with recurrent pregnancy loss. J Obstetr Gynaecol Res. 2009;35:1061-8.

Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil steril. 2002;77:342-7.

Azem F, Many A, Ben Ami I. Increased rates of thrombophilia in women with repeated IVF failures. Human reproduction (Oxford, England). 2004;19:368-70.

Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reproduct Biomed Online. 2006;12:322-7.

Qublan HS, Eid SS, Ababneh HA. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Human Reproduct (Oxford, England). 2006;21:2694-8.

Bellver J, Soares SR, Alvarez C. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Human Reproduct (Oxford, England) 2008;23:278-84.

Vaquero E, Lazzarin N, Caserta D. Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. Eur J obstetr Gynecol Reproduct Biol. 2006;125:79-84.

Rudick B, Su HI, Sammel MD, Kovalevsky G, Shaunik A, Barnhart K. Is factor V Leiden mutation a cause of in vitro fertilization failure? Fertil steril. 2009;92:1256-9.

Simur A, Ozdemir S, Acar H. Repeated in vitro fertilization failure and its relation with thrombophilia. Gynecol obstetric investigation. 2009;67:109-12.